STEPHANIE WRIGHTSMAN: Open Payments
NPI 1497484083 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 37 payments from 7 companies in 2025. Trend: 2023 $625 · 2024 $385 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $212 |
| Teva Pharmaceuticals USA, Inc. | 6 | $199 |
| Braeburn Inc. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Indivior Inc. | 3 | $46 |
| ABBVIE INC. | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: INGREZZA, AUSTEDO XR, BRIXADI, INVEGA SUSTENNA, SUBLOCADE, UZEDY, VRAYLAR, ARISTADA.
Industry payments across OK — which companies pay providers there.
